Dr Caroline Abbott (PhD) - publications

2011

• Abbott, C., Malik, R., van Ross, E., Kulkarni, J. & Boulton, A (2011). Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the u.k. Diabetes Care, 34(10), 2220-4. eScholarID:133361 | DOI:10.2337/dc11-1108

2010

• Abbott, C., Chaturvedi, N., Malik, R., Salgami, E., Yates, A., Pemberton, P. & Boulton, A (2010). Explanations for the lower rates of diabetic neuropathy in Indian Asians versus Europeans. Diabetes Care, 33(6), 1325-30. eScholarID:85643 | PMID:20215455 | DOI:10.2337/dc09-2067
• Tavakoli, M., Quattrini, C., Abbott, C., Kallinikos, P., Marshall, A., Finnigan, J., Morgan, P., Efron, N., Boulton, A. & Malik, R (2010). Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care, 33(8), 1792-7. eScholarID:110926 | DOI:10.2337/dc10-0253

2009

• Vanross E, Johnson S, Abbott CA. (2009). Effects of early mobilization on unhealed dysvascular transtibial amputation stumps: a clinical trial. Arch Phys Med Rehabil, 90( 4), 610-7. eScholarID:1d21179 | DOI:10.1016/j.apmr.2008.10.026

2005

• Abbott CA, Garrow A, Carrington AL, Morris JJA, Van Ross EE, Boulton AJM. (2005). Foot ulcer risk is lower in South-Asian and African-Caribbean compared with European diabetic patients in the UK: The North-West diabetes foot study care. Diabetes Care, 28(8), 1869-75. eScholarID:1d26765 | DOI:10.2337/diacare.28.8.1869

2003

• Malik RA, P Kallnikos, Abbott CA, van Schie CH M, P Morgan, N Efron, Boulton AJM. (2003). Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia, 46(5), 683-688. eScholarID:1d25527

2002

• AN Paisley, Abbott CA, van Schie CH M, Boulton AJM. (2002). A comparison of the Neuropen against standard quantitative sensory threshold measures for assessing peripheral nerve function. Diabetic Medicine, 19, 400-405. eScholarID:1d5087
• A L Carrington, J E Shaw, van Schie CH M, Abbott CA, Loretta Vileikyte, Boulton AJM. (2002). Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care, 25(11), 2010-2015. eScholarID:1d3597 | DOI:10.2337/diacare.25.11.2010
• N Chaturvedi, Abbott CA, A Whalley, P Widdows, SY Leggetter, Boulton AJM. (2002). Risk of diabetes-related amputation in South Asians versus Europeans in the UK. Diabetic Medicine, 19, 99-162. eScholarID:1d3157
• Abbott, CA, AL Carrington, H Ashe, S Bath, L C Every, J Griffiths, AW Hann, A Hussein, N Jackson, KE Johnson, CH Ryder, R Torkington, ERE Van Ross, AM Whalley, P Widdows, S Williamson, Boulton, AJM. (2002). The North West Diabetes Foot Care Study: Incidence of, and Risk Factors for, New Diabetic Foot Ulceration in a Community-Based Patient Cohort. Diabetic Medicine, 19, 377-384. eScholarID:1d3160

2001

• A L Carrington, Abbott CA, J Griffiths, N Jackson, SR Johnson, J Kulkarni, ERE Van Ross, Boulton AJM. (2001). A Foot care program for diabetic unilateral lower limb amputees. Diabetes Care, 24, 216-221. eScholarID:1d3107
• Carrington AL, Abbott CA, Griffiths J, Jackson N, Johnson SR, Kulkarni J, Van Ross ERE, Boulton AJM. (2001). Peripheral vascular and nerve function associated with lower limb amputation in people with and without diabetes. Clinical Science, 101, 261-266. eScholarID:1d3154

1999

• Caroline HM Van Schie, Abbott CA, Loretta Vileikyte, JE Shaw, S Hollis, Boulton AJM. (1999). A comparative study of the Podotrack, a simple semiquantitative plantar pressure measuring device, and the optical pedobaragraph in the assessment of pressures under the diabetic foot. Diabetic Medicine, 16, 154-159. eScholarID:1d2960
• Malik RA, S Williamson, Abbott CA, A L Carrington, J Iqbal, Boulton AJM, W Schady. (1999). Effect of the angiotensin-converting-enzyme inhibitor trandolapril on diabetic peripheral and autonomic neuropathy: a randomised double-blind controlled trial. Lancet, 352, 1978-1981. eScholarID:1d3100

1998

• Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJM. (1998). A Prospective Multi-Centre Study of the Incidence of, and Predictive Risk Factors for, Diabetic Neuropathic Foot Ulceration. Diabetes Care, 21, 1071-1075. eScholarID:1d26893
• Shaw JE, van Schie CH M, Carrington AL, Abbott CA, Boulton AJM. (1998). An analysis of dynamic forces transmitted through the foot in diabetic neuropathy. Diabetes Care, 21, 1955-1959. eScholarID:1d26891
• Abbott CA, L Vileikyte, S Williamson, AL Carrington, Boulton AJM. (1998). Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care, 21, 1071-1075. eScholarID:1d24398
• EB Jude, Abbott CA, MJ Young, SG Anderson, Douglas, Boulton AJM. (1998). The potential role of cell adhesion molecules in the pathogenesis ofdiabetic neuropathy. Diabetologia, 41, 330-336. eScholarID:1d24401

1997

• Shaw JE, Abbott CA, Tindle K, Hollis S, Boulton AJM. (1997). A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia, 41, 299-301. eScholarID:1d26895

1995

• Abbott CA, Mackness MI, Kumar S, Boulton AJM, Durrington PN. (1995). Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol, 15( 11), 1812-8. eScholarID:1d19561

1994

• M-C Blatter Garin, Abbott CA, S Messmer, Mackness MI, Durrington PN, D Pometta, RW James. (1994). Quantification of human serum paraoxonase by enzyme-linked immunoassay:population differences in protein concentrations. Biochemical Journal, 304, 549-554. eScholarID:1d24374

1993

• Mackness M, Arrol S, Abbott CA, Durrington PN. (1993). Is paraoxonase related to atherosclerosis. Chem Biol Interact, 87( 1-3), 161-71. eScholarID:1d19519
• Mackness MI, S Arrol, Abbott CA, Durrington PN. (1993). Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis, 104, 129-135. eScholarID:1d24372
• Abbott CA, Mackness MI, S Kumar, AO Olukoga, C Gordon, S Arrol, Boulton AJM, Durrington PN. (1993). The relationship between serum butyrylcolinesterase activity, hypertriglyceridaemiaand insuliln sensitivity in diabetes mellitus. Clinical Science, 85, 77-81. eScholarID:1d24370
• Mackness MI, Abbott CA, S Arrol, Durrington PN. (1993). The role of high-density lipoprotein and lipid soluble anti-oxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochemical Journal, 294, 829-834. eScholarID:1d24368

1992

• Morley B, Abbott CA, Sharpe J, Lida J, Chan-Thomas P, Wood W. (1992). A single beta-globin locus control region element (5' hypersensitive site 2) is sufficient for developmental regulation of human globin genes in transgenic mice. Mol Cell Biol, 12( 5), 2057-66. eScholarID:1d21181

1991

• Morley B, Abbott CA, Wood W. (1991). Regulation of human fetal and adult globin genes in mouse erythroleukemia cells. Blood, 78( 5), 1355-63. eScholarID:1d21182